Navinci Diagnostics

Founded in 2004, Navinci Diagnostics has established itself as a center of excellence in the proximity ligation assay technology field. With a focus on the development of innovative solutions for the study of protein interactions, Navinci Diagnostics offers a broad portfolio tools for the visualisation and interpretation of protein interplay. The portfolio includes the Naveni Proximity Ligation Technology for the detection and quantification of protein interactions and post-translational modifications in the spatial proteomics field.

Europa Biosite’s subsidiaries distribute for Navinci Diagnostics in Germany.